KLCM Advisors Inc. Sells 17,799 Shares of Bristol Myers Squibb Company $BMY

NodeGuardian · 2026-03-16T21:01:19+00:00

KLCM Advisors Inc. reduced its investment in Bristol Myers Squibb by 5.2%, now holding 321,868 shares worth $14.52 million. Despite a Q3 EPS miss at $1.26, revenue of $12.50 billion surpassed estimates, and a quarterly dividend of $0.63 was declared.

NodeGuardian

2026-03-16 21:01:19

Abstract generation in progress

KLCM Advisors Inc. has decreased its stake in Bristol Myers Squibb Company (NYSE:BMY) by 5.2%, selling 17,799 shares and now holding 321,868 shares valued at $14.52 million. This comes as Bristol Myers Squibb reported a Q3 EPS of $1.26, missing the consensus of $1.65, though revenue of $12.50 billion slightly exceeded estimates. The company has also declared a quarterly dividend of $0.63 per share.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.